Cyclerion Therapeutics Inc (CYCN:NASDAQ)

$1.31 0.01 (0.77%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 85

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Cyclerion Therapeutics Inc (CYCN:NASDAQ) News Sources

Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

Yahoo Finance UK

external link

CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26

Yahoo Finance

external link
CYCN stock
CYCN stock price
CYCN stock price today
CYCN stock prediction
CYCN earnings date
CYCN news
CYCN price
CYCN share
CYCN share price
CYCN shares
CYCN ceo
CYCN premarket
$CYCN
CYCN ticker
CYCN after hours
CYCN stock
CYCN stock price
CYCN stock price today
CYCN stock prediction
CYCN earnings date
CYCN news
CYCN price
CYCN share
CYCN share price
CYCN shares
CYCN ceo
CYCN premarket
$CYCN
CYCN ticker
CYCN after hours

Cyclerion Therapeutics Inc (CYCN:NASDAQ) FAQs

toggle

What is the current price of Cyclerion Therapeutics Inc (CYCN:NASDAQ)?

The current price of Cyclerion Therapeutics Inc (CYCN:NASDAQ) is $1.31.


toggle

Cyclerion Therapeutics Inc (CYCN:NASDAQ) absolute price change since previous trading day?

The absolute price change of Cyclerion Therapeutics Inc (CYCN:NASDAQ) since the previous trading day is $0.01.


toggle

Cyclerion Therapeutics Inc (CYCN:NASDAQ) percentage price change since previous trading day?

The percentage price change of Cyclerion Therapeutics Inc (CYCN:NASDAQ) since the previous trading day is 0.77%.


toggle

What is This Week's average sentiment score for Cyclerion Therapeutics Inc (CYCN:NASDAQ)?

This Week's average sentiment score for Cyclerion Therapeutics Inc (CYCN:NASDAQ) is 85 out of 100.


toggle

What is This Week's average sentiment for Cyclerion Therapeutics Inc (CYCN:NASDAQ)?

This Week's sentiment for Cyclerion Therapeutics Inc (CYCN:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.